Chiral drugs

Louis Pasteur, foto av Paul Nadar, Crisco edit

Cahn-Ingold-Prelog convention

Easson-Stedman Model

File:Penicillamine enantiomers.png

Penicillamine enantiomers

Ketamine enantiomers

Chiral Drugs are a class of pharmaceutical drugs whose molecules exhibit chirality, meaning they possess two or more forms (called enantiomers) that are mirror images of each other but cannot be superimposed. This property is significant in pharmacology because the different enantiomers of a drug can have vastly different effects on the body. The study of chiral drugs is a crucial aspect of medicinal chemistry and pharmacology, as the enantiomeric purity of a drug can affect its safety, efficacy, and pharmacokinetics.

Overview

Chirality is a geometric property of some molecules that is characterized by the molecule's inability to be superimposed on its mirror image. In the context of pharmaceuticals, this means that a chiral drug can exist in two forms (enantiomers) that are mirror images of each other. These enantiomers are designated as either R (from the Latin rectus, meaning right) or S (from the Latin sinister, meaning left).

The importance of chirality in drugs lies in the fact that most biological molecules (such as proteins, enzymes, and receptors) are themselves chiral. As a result, the different enantiomers of a chiral drug can interact with these biological molecules in different ways, leading to differences in the drug's pharmacological effects.

Chiral Drugs in Medicine

In medicine, the distinction between different enantiomers of a drug can be critical. One enantiomer may be therapeutically active, while the other is less active or may even cause adverse effects. For example, the R enantiomer of the drug thalidomide is effective as a sedative and anti-nausea medication, while the S enantiomer can cause severe birth defects. This tragic outcome in the 1950s and 1960s, when thalidomide was used by pregnant women, highlighted the importance of chirality in drug development and led to stricter regulations and controls in drug manufacturing and approval processes.

Development and Regulation

The development of chiral drugs involves the synthesis of enantiomerically pure compounds, a process known as chiral synthesis or asymmetric synthesis. This can be challenging, as traditional chemical synthesis methods often produce a racemic mixture containing equal amounts of both enantiomers. Advances in chemistry and pharmacology have led to the development of methods for the synthesis of enantiomerically pure drugs, including chiral catalysts and biocatalysts.

Regulatory agencies, such as the Food and Drug Administration (FDA) in the United States, have established guidelines for the development and approval of chiral drugs. These guidelines require that drug manufacturers provide detailed information on the chirality of their products and demonstrate the safety and efficacy of the therapeutically active enantiomer.

Clinical Implications

The clinical implications of chiral drugs are significant. The use of enantiomerically pure drugs can improve therapeutic outcomes by increasing efficacy and reducing side effects. Additionally, understanding the pharmacokinetics and pharmacodynamics of each enantiomer can lead to more precise dosing regimens and better patient management.

Conclusion

Chiral drugs represent a significant and complex area of pharmaceutical science, with important implications for drug development, regulatory approval, and clinical practice. The study of chirality and its effects on drug action is a critical aspect of modern medicinal chemistry and pharmacology, ensuring that drugs are safe, effective, and tailored to meet the specific needs of patients.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian